MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fidock, D. A.
Right arrow Articles by Wellems, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fidock, D. A.
Right arrow Articles by Wellems, T. E.

Vol. 54, Issue 6, 1140-1147, December 1998

Cycloguanil and Its Parent Compound Proguanil Demonstrate Distinct Activities against Plasmodium falciparum Malaria Parasites Transformed with Human Dihydrofolate Reductase

David A. Fidock,1 Takashi Nomura, and Thomas E. Wellems

Malaria Genetics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0425

The lack of suitable antimalarial agents to replace chloroquine and pyrimethamine/sulfadoxine threatens efforts to control the spread of drug-resistant strains of the malaria parasite Plasmodium falciparum. Here we describe a transformation system, involving WR99210 selection of parasites transformed with either wild-type or methotrexate-resistant human dihydrofolate reductase (DHFR), that has application for the screening of P. falciparum-specific DHFR inhibitors that are active against drug-resistant parasites. Using this system, we have found that the prophylactic drug cycloguanil has a mode of pharmacological action distinct from the activity of its parent compound proguanil. Complementation assays demonstrate that cycloguanil acts specifically on P. falciparum DHFR and has no other significant target. The target of proguanil itself is separate from DHFR. We propose a strategy of combination chemotherapy incorporating the use of multiple parasite-specific inhibitors that act at the same molecular target and thereby maintain, in combination, their effectiveness against alternative forms of resistance that arise from different sets of point mutations in the target. This approach could be combined with traditional forms of combination chemotherapy in which two or more compounds are used against separate targets.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
D. Japrung, U. Leartsakulpanich, S. Chusacultanachai, and Y. Yuthavong
Conflicting Requirements of Plasmodium falciparum Dihydrofolate Reductase Mutations Conferring Resistance to Pyrimethamine-WR99210 Combination
Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4356 - 4360.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. S. Freundlich, F. Wang, H.-C. Tsai, M. Kuo, H.-M. Shieh, J. W. Anderson, L. J. Nkrumah, J.-C. Valderramos, M. Yu, T. R. S. Kumar, et al.
X-ray Structural Analysis of Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase as a Pathway toward the Optimization of Triclosan Antimalarial Efficacy
J. Biol. Chem., August 31, 2007; 282(35): 25436 - 25444.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
S. Takebe, W. H. Witola, B. Schimanski, A. Gunzl, and C. Ben Mamoun
Purification of Components of the Translation Elongation Factor Complex of Plasmodium falciparum by Tandem Affinity Purification
Eukaryot. Cell, April 1, 2007; 6(4): 584 - 591.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. B. S. Sidhu, Q. Sun, L. J. Nkrumah, M. W. Dunne, J. C. Sacchettini, and D. A. Fidock
In Vitro Efficacy, Resistance Selection, and Structural Modeling Studies Implicate the Malarial Parasite Apicoplast as the Target of Azithromycin
J. Biol. Chem., January 26, 2007; 282(4): 2494 - 2504.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. H. Witola, G. Pessi, K. El Bissati, J. M. Reynolds, and C. B. Mamoun
Localization of the Phosphoethanolamine Methyltransferase of the Human Malaria Parasite Plasmodium falciparum to the Golgi Apparatus
J. Biol. Chem., July 28, 2006; 281(30): 21305 - 21311.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. Nduati, S. Hunt, E. M. Kamau, and A. Nzila
2,4-Diaminopteridine-Based Compounds as Precursors for De Novo Synthesis of Antifolates: a Novel Class of Antimalarials
Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3652 - 3657.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. L. Omara-Opyene, P. A. Moura, C. R. Sulsona, J. A. Bonilla, C. A. Yowell, H. Fujioka, D. A. Fidock, and J. B. Dame
Genetic Disruption of the Plasmodium falciparum Digestive Vacuole Plasmepsins Demonstrates Their Functional Redundancy
J. Biol. Chem., December 24, 2004; 279(52): 54088 - 54096.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. L. Waller, R. A. Muhle, L. M. Ursos, P. Horrocks, D. Verdier-Pinard, A. B. S. Sidhu, H. Fujioka, P. D. Roepe, and D. A. Fidock
Chloroquine Resistance Modulated in Vitro by Expression Levels of the Plasmodium falciparum Chloroquine Resistance Transporter
J. Biol. Chem., August 29, 2003; 278(35): 33593 - 33601.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. R. Kuo, H. R. Morbidoni, D. Alland, S. F. Sneddon, B. B. Gourlie, M. M. Staveski, M. Leonard, J. S. Gregory, A. D. Janjigian, C. Yee, et al.
Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase: COMPOUND ACTIVITY AND STRUCTURAL DATA
J. Biol. Chem., May 30, 2003; 278(23): 20851 - 20859.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Akompong, M. Kadekoppala, T. Harrison, A. Oksman, D. E. Goldberg, H. Fujioka, B. U. Samuel, D. Sullivan, and K. Haldar
trans Expression of a Plasmodium falciparum Histidine-rich Protein II (HRPII) Reveals Sorting of Soluble Proteins in the Periphery of the Host Erythrocyte and Disrupts Transport to the Malarial Food Vacuole
J. Biol. Chem., August 2, 2002; 277(32): 28923 - 28933.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Perozzo, M. Kuo, A. b. S. Sidhu, J. T. Valiyaveettil, R. Bittman, W. R. Jacobs Jr., D. A. Fidock, and J. C. Sacchettini
Structural Elucidation of the Specificity of the Antibacterial Agent Triclosan for Malarial Enoyl Acyl Carrier Protein Reductase
J. Biol. Chem., April 5, 2002; 277(15): 13106 - 13114.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. K. Mehlotra, H. Fujioka, P. D. Roepe, O. Janneh, L. M. B. Ursos, V. Jacobs-Lorena, D. T. McNamara, M. J. Bockarie, J. W. Kazura, D. E. Kyle, et al.
Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America
PNAS, October 23, 2001; 98(22): 12689 - 12694.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
Y.-L. Tsai, R. E. Hayward, R. C. Langer, D. A. Fidock, and J. M. Vinetz
Disruption of Plasmodium falciparum Chitinase Markedly Impairs Parasite Invasion of Mosquito Midgut
Infect. Immun., June 1, 2001; 69(6): 4048 - 4054.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Kadekoppala, K. Kline, T. Akompong, and K. Haldar
Stable Expression of a New Chimeric Fluorescent Reporter in the Human Malaria Parasite Plasmodium falciparum
Infect. Immun., April 1, 2000; 68(4): 2328 - 2332.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. B. Mamoun, I. Y. Gluzman, S. Goyard, S. M. Beverley, and D. E. Goldberg
A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum
PNAS, July 20, 1999; 96(15): 8716 - 8720.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics